ARCHIVES
VOL. 9, ISSUE 12 (2024)
An overview of insect derived bioactive compounds with therapeutic potential
Authors
Praveen Javali R, Issac V, Cherian, Abhishek Vijukumar, Nair Aiswarya Hemachandran
Abstract
Insects, among the most diverse groups of
organisms, provide as a significant source of bioactive chemicals with
therapeutic potential, historically utilized in medicine via honeybee products
such as propolis and Apitoxin. Progress in molecular biology has unveiled their
antibacterial, anti-inflammatory, anticancer, and neuroprotective properties.
Antimicrobial peptides (AMPs) such as defensins and cecropins demonstrate
effectiveness against drug-resistant bacteria, whereas bee venom, royal jelly,
and propolis possess antioxidant and immunomodulatory characteristics.
Challenges encompass sustainability, chemical variability, and scalability for
pharmaceutical applications. Synthetic biology and biotechnology provide
solutions; yet, ethical, regulatory, and quality concerns remain. This domain
emphasizes the necessity of safeguarding insects and tackling global health
issues such as antibiotic resistance and cancer, which could revolutionize
pharmacological methodologies.
Download
Pages:146-152
How to cite this article:
Praveen Javali R, Issac V, Cherian, Abhishek Vijukumar, Nair Aiswarya Hemachandran "An overview of insect derived bioactive compounds with therapeutic potential". International Journal of Entomology Research, Vol 9, Issue 12, 2024, Pages 146-152
Download Author Certificate
Please enter the email address corresponding to this article submission to download your certificate.